These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26974957)

  • 1. Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice.
    Xue X; Yang JY; He Y; Wang LR; Liu P; Yu LS; Bi GH; Zhu MM; Liu YY; Xiang RW; Yang XT; Fan XY; Wang XM; Qi J; Zhang HJ; Wei T; Cui W; Ge GL; Xi ZX; Wu CF; Liang XJ
    Nat Nanotechnol; 2016 Jul; 11(7):613-20. PubMed ID: 26974957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
    Xu W; Zhu JP; Angulo JA
    Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H; Iyo M; Hashimoto K
    Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
    Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
    PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
    Park SW; Shen X; Tien LT; Roman R; Ma T
    J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential action of methamphetamine on tyrosine hydroxylase and dopamine transport in the nigrostriatal pathway of μ-opioid receptor knockout mice.
    Park SW; He Z; Shen X; Roman RJ; Ma T
    Int J Neurosci; 2012 Jun; 122(6):305-13. PubMed ID: 22329540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
    Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
    Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies.
    Hirata H; Cadet JL
    J Neurochem; 1997 Aug; 69(2):780-90. PubMed ID: 9231739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
    Zhu JP; Xu W; Angulo JA
    Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
    Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
    Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A; Wells PG
    Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.
    Angoa-Pérez M; Kane MJ; Francescutti DM; Sykes KE; Shah MM; Mohammed AM; Thomas DM; Kuhn DM
    J Neurochem; 2012 Mar; 120(6):1097-107. PubMed ID: 22191803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
    Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
    J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.